Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05510050 · ClinicalTrials.gov registry record · NA
Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and Related Variables in Men and Women
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05510050 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 60 participants.
The verdict
NCT05510050, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The present study will compare the effect of Manapol to DaltonMax on select measures of health. Currently, both ingredients are sold both as a stand-alone dietary supplement and as an active ingredient within various multi-nutrient products. Immune function will be assessed using blood samples to determine white blood cell counts and distributions, and cytokine levels with/without lipopolysaccharide (LPS) challenge. Additionally, effects specific to antioxidant function and glucose regulation, glucose, insulin, lipid peroxidation, and advanced oxidation protein products will be observed. Antioxidant capacity will also be measured. as well as completion of weekly questionnaires regarding gut health, and microbiome analysis.
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Aloe Vera Extract 1
- DIETARY_SUPPLEMENT Aloe Vera Extract 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2023-03-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05510050
The ClinicalTrials.gov registry entry for NCT05510050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT05510050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05510050 about?
NCT05510050 is a clinical study titled "Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and Related Variables in Men and Women". The present study will compare the effect of Manapol to DaltonMax on select measures of health. Currently, both ingredients are sold both as a stand-alone dietary supplement and as an active ingredient within various multi-nutrient products. Immune function will be assessed using blood samples to d...
What is the current status of trial NCT05510050?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-05-13. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT05510050?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Aloe Vera Extract 1 (DIETARY_SUPPLEMENT), Aloe Vera Extract 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05510050?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.